Linking the Declarations of Helsinki and of Taipei: Critical Challenges of Future-Oriented Research Ethics

Expansion of data-driven research in the 21st century has posed challenges in the evolution of the international agreed framework of research ethics. The World Medical Association (WMA)’s Declaration of Helsinki (DoH) has provided ethical principles for medical research involving humans since 1964,...

Descripción completa

Detalles Bibliográficos
Autores principales: Kurihara, Chieko, Baroutsou, Varvara, Becker, Sander, Brun, Johan, Franke-Bray, Brigitte, Carlesi, Roberto, Chan, Anthony, Collia, Luis Francisco, Kleist, Peter, Laranjeira, Luís Filipe, Matsuyama, Kotone, Naseem, Shehla, Schenk, Johanna, Silva, Honorio, Kerpel-Fronius, Sandor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7723451/
https://www.ncbi.nlm.nih.gov/pubmed/33324212
http://dx.doi.org/10.3389/fphar.2020.579714
Descripción
Sumario:Expansion of data-driven research in the 21st century has posed challenges in the evolution of the international agreed framework of research ethics. The World Medical Association (WMA)’s Declaration of Helsinki (DoH) has provided ethical principles for medical research involving humans since 1964, with the last update in 2013. To complement the DoH, WMA issued the Declaration of Taipei (DoT) in 2016 to provide additional principles for health databases and biobanks. However, the ethical principles for secondary use of data or material obtained in research remain unclear. With such a perspective, the Working Group on Ethics (WGE) of the International Federation of Associations of Pharmaceutical Physicians and Pharmaceutical Medicine (IFAPP) suggests a closer scientific linkage in the DoH to the DoT focusing specifically on areas that will facilitate data-driven research, and to further strengthen the protection of research participants.

Ejemplares similares